Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-06 Monohon Ted Chief Accounting Officer & VP Sale −1,871 $0.98 $2K 27,440
2023-02-01 Monohon Ted Chief Accounting Officer & VP Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2022-12-05 Monohon Ted Chief Accounting Officer & VP Shares withheld for taxes −1,640 $0.72 $1K 29,311
2022-09-06 Monohon Ted Chief Accounting Officer & VP Shares withheld for taxes −1,520 $1.64 $2K 30,951
2022-06-29 Monohon Ted Chief Accounting Officer & VP Grant or award · Stock Option (right to buy) +250,000 250,000
2022-06-06 Monohon Ted Chief Accounting Officer & VP Shares withheld for taxes −1,529 $3.12 $5K 32,471
2022-03-03 Monohon Ted Chief Accounting Officer & VP Grant or award +34,000 34,000
2021-12-14 Monohon Ted Chief Accounting Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2021-02-09 Monohon Ted Chief Accounting Officer Grant or award · Employee Stock Option (right to buy) +20,000 20,000

Page 1 of 1 · 9 trades